Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces Completion of Its 20th Pre-Clinical Study
Marijuana Stocks, Finance, & InvestingUncategorized March 17, 2021
Cybin announces two new drug candidates for its R&D pipeline as its pre-clinical research deepens.
Read moreCalifornia Gives Localities $15M In Cannabis Equity Grants
Marijuana Stocks, Finance, & InvestingUncategorized March 17, 2021
California officials have awarded $15 million in grant funding through the Governor’s Office of Business and Economic Development (GO-Biz) and Bureau of Cannabis Control’s Cannabis Equity Grants program.
Read moreNuminus Wellness Inc. Announces $30 Million Bought Deal Public Offering
Marijuana Stocks, Finance, & InvestingUncategorized March 16, 2021
Numinus announces a CAD$30 million bought deal financing with units priced at CAD$1.25.
Read moreWill Court Challenges Lead To Psychedelics Legalization?
Marijuana Stocks, Finance, & InvestingUncategorized March 16, 2021
A Seattle doctor is suing the DEA for blocking access to psilocybin. Could this be the quickest road to psychedelic drug legalization?
Read moreRed Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit
Marijuana Stocks, Finance, & InvestingUncategorized March 16, 2021
Red Light Holland imports psilocybin truffles into Canada from its Netherlands supply source.
Read moreThe Race to Patent Psychedelics Is Just Getting Started
Marijuana Stocks, Finance, & InvestingUncategorized March 14, 2021
The author and podcast host Tim Ferriss has done his share of heavy lifting when it comes to supporting and promoting research on psychedelic drugs.
Read moreMindMed Announces C$19.5 Million Bought Deal Private Placement Offering
Marijuana Stocks, Finance, & InvestingUncategorized March 14, 2021
MindMed raises CAD$19.5 million selling units at CAD$3.25.
Read moreMINDCURE (CSE: MCUR) (OTCQB: MCURF) Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study
Marijuana Stocks, Finance, & InvestingUncategorized March 14, 2021
This approval is a key step forward in the development of the company’s iSTRYM digital therapeutics platform
Read moreRed-Hot Sale On Psychedelic Stocks
Marijuana Stocks, Finance, & InvestingUncategorized March 14, 2021
The psychedelic drug industry continues to advance by leaps-and-bounds. But psychedelic drug stocks are well off recent highs. The sale is on!
Read moreLifetime psychedelic use may reduce likelihood of hypertension
Marijuana Stocks, Finance, & InvestingUncategorized March 13, 2021
Lifetime classic psychedelic use, particularly tryptamines, may be linked to lower odds for hypertension in the previous year, according to data published in Hypertension.
Read more